Origins and Benefits of Biologically Active Components in Human Milk
Origins and Benefits of Biologically Active Components in Human Milk
批准号:
10683486
负责人:
Lars Bode
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-06-01 至 2024-05-31
关键词:
AcademiaAddressAffectAgeAwardBig DataBiologyBrainCategoriesCharacteristicsChild NutritionCognitionCollaborationsCommunicable DiseasesDevelopmentDiseaseEnsureFloridaFutureGoalsGovernmentHuman MilkHypersensitivityImmuneIndustryInfantInfant HealthInfant formulaLactationLengthMammary glandMaternal HealthMembraneMetabolic DiseasesMothersNational Institute of Allergy and Infectious DiseaseNational Institute of Child Health and Human DevelopmentNational Institute of Diabetes and Digestive and Kidney DiseasesNatureNutrientOligosaccharidesOralPersonsPoliciesPregnancyPremature InfantPropertyResearchResearch PersonnelSafetyScienceSourceStrategic PlanningStudentsTravelUnderrepresented PopulationsUnited States National Institutes of Healthcareercareer developmentcollaborative environmentcomplex biological systemseffective therapygut healthimprovedinnovationinterestmilk fat globulemother nutritionnext generationnovelnutritionpostersprofessional studentssymposiumtechnological innovationtechnology development
中文摘要
项目总结
第五届FASE B科学研究会议(SRC)主题为“生物学的起源和益处”
将于2023年6月4日至9日在佛罗里达州墨尔本举行的“母乳中的活性成分”将是
希望加深对这一科学主题的理解的专业人士。会议将于
将以前的和新的演讲者/与会者聚集在一起,促进这一领域的思想多样性。
这次会议具有很强的跨学科性质,利益相关者来自工业界、学术界
和政府联合起来,更好地理解母乳是一种复杂的生物
这一制度的最终目标是改善母婴健康。
会议的大部分会议将讨论关键的科学研究主题和目标。
在NICHD 2020战略计划中概述:“研究所特别感兴趣[NICHD]是一个更好的
了解母乳的组成和功能,母体营养的影响和
孕期长短对母乳成分和哺乳的影响及最佳营养来源
以及向婴儿,特别是早产儿提供营养的方式。此外,大会
解决2020年NICHD战略计划中的十个令人向往的目标之一:“优化婴儿
通过合成母乳、捕捉其所有成分和特性来生存,以及
根据婴儿母亲的特点对其进行个性化处理。
了解母乳成分的来源和益处也与美国国立卫生研究院有关
NICHD以外的机构影响肠道健康和发育以及代谢性疾病
(NIDDK)和预防过敏和传染病(NIAID)。事实上,人类乳汁
组件可作为新的、安全和有效的疾病治疗方法的模板
所有年龄段的人,因此,与许多其他NIH研究所相关。
最后,会议将提供一个强烈的“职业发展”的重点,支持学生和
具有职业抱负的早期职业调查员。因此,我们的具体目标是
补贴早期职业调查员类别特邀演讲者的注册和旅费
以优秀的摘要、海报和口头陈述为学生提供旅游奖励。
支持母乳领域的下一代研究人员、临床医生和教育工作者
哺乳将确保NICHD目前的目标和抱负目标不会实现
不仅是今天,而且是在未来。
英文摘要
PROJECT SUMMARY
The 5th FASEB Science Research Conference (SRC) on “Origins and Benefits of Biologically
Active Components in Human Milk” in Melbourne, Florida, June 4-9, 2023, will be a gathering of
professionals who wish to deepen their understanding of this scientific topic. The conference will
bring together previous and new speakers/attendees to promote diversity of thought in this space.
The conference has a strong inter-disciplinary nature, with stakeholders from industry, academia
and government coming together to better understand human milk as a complex biological
system with the ultimate goal of improving maternal & infant health.
A majority of the conference sessions will address key scientific research themes and objectives
outlined in the NICHD Strategic Plan 2020: “Of unique interest to the institute [NICHD] is a better
understanding of the composition and function of human milk, the effect of maternal nutrition and
length of gestation on human milk composition and lactation, and the optimal source of nutrition
and mode if nutrient delivery to the infant, especially preterm infants.” In addition, the conference
addresses one of the ten aspirational goals in the NICHD Strategic Plan 2020: “Optimize infant
survival by synthesizing human milk, capturing all its components and properties, and
individualizing it to the characteristics of the infant’s mother.”
Understanding the origins and benefits of human milk components is also relevant to NIH
institutes other than NICHD as they affect gut health and development and metabolic diseases
(NIDDK) and protect from allergy and infectious diseases (NIAID). In fact, human milk
components may serve as templates for novel, safe and effective treatments for diseases in
people of all ages and, therefore, be of relevance to many of the other NIH institutes.
Finally, the conference will offer a strong “career development” focus, supporting students and
early career investigators with their professional ambitions. We therefore specifically aim to
subsidize registration and travel of invited speakers in the early career investigator category and
provide travel awards for students with outstanding abstracts, posters and oral presentations.
Supporting the next generation of researchers, clinicians and educators in the field of human milk
and lactation will ensure that NICHD’s current objectives and aspirational goals will be met not
only today, but also in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Milk Analytics Core
-
批准号:10487510
-
项目类别:
-
资助金额:$20.03万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
-
批准号:10681290
-
项目类别:
-
资助金额:$123.91万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Milk Analytics Core
-
批准号:10681304
-
项目类别:
-
资助金额:$20.26万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Exploring Associations between Human Milk Oligosaccharides and Atherosclerosis Risk Factors in Infancy and Early Childhood
-
批准号:10195374
-
项目类别:
-
资助金额:$22.6万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Exploring Associations between Human Milk Oligosaccharides and Atherosclerosis Risk Factors in Infancy and Early Childhood
-
批准号:10491367
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
-
批准号:10659295
-
项目类别:
-
资助金额:$101.57万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
-
批准号:10309708
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Milk Analytics Core
-
批准号:10309713
-
项目类别:
-
资助金额:$20.51万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
-
批准号:10487493
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Exploring human milk oligosaccharides and malaria risk in breastfed infants
-
批准号:10226366
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2020
-
负责人:Lars Bode
-
依托单位:
Exploring human milk oligosaccharides and malaria risk in breastfed infants
-
批准号:10057627
-
项目类别:
-
资助金额:$20.12万
-
财政年份:2020
-
负责人:Lars Bode
-
依托单位:
Exploring Associations between Human Milk Oligosaccharides and Growth, Body Composition and Obesity Risk in Infancy and Early Childhood
-
批准号:9317205
-
项目类别:
-
资助金额:$23.26万
-
财政年份:2017
-
负责人:Lars Bode
-
依托单位:
Exploring Oligosaccharide Synthesis in Human Mammary Gland Epithelial Cells
-
批准号:8892907
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2015
-
负责人:Lars Bode
-
依托单位:
Disialyl oligosaccharides as Necrotizing Enterocolitis therapeutics
-
批准号:9048196
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2015
-
负责人:Lars Bode
-
依托单位:
Selective Inhibitors of Plasmodium Falciparum G6PD as Novel Antimalarials
-
批准号:8911238
-
项目类别:
-
资助金额:$39.8万
-
财政年份:2014
-
负责人:Lars Bode
-
依托单位:
Selective Inhibitors of Plasmodium Falciparum G6PD as Novel Antimalarials
-
批准号:8632677
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2014
-
负责人:Lars Bode
-
依托单位:
Screening for Human Milk Oligosaccharides that Protect Infants from HIV Infection
-
批准号:8090034
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2010
-
负责人:Lars Bode
-
依托单位:
Fusing Glycobiology and Nutritional Sciences to Prevent Necrotizing Enterocolitis
-
批准号:8119080
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2009
-
负责人:Lars Bode
-
依托单位:
Identification of G6PD inhibitors for the development of novel antimalarial drugs
-
批准号:7905094
-
项目类别:
-
资助金额:$23.34万
-
财政年份:2009
-
负责人:Lars Bode
-
依托单位:
Fusing Glycobiology and Nutritional Sciences to Prevent Necrotizing Enterocolitis
-
批准号:7924735
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Lars Bode
-
依托单位:
海外基金